نتائج البحث

| group1 = [[5-HT3 antagonist|5-HT3 Serotonin ion channel antagonist]]s | group5 = [[H1 antagonist|H₁ antagonists]] <br/>([[Histamine antagonist|Antihistamines]])

[[Category:5-HT3 antagonists]]

'''أزاسيترون Azasetron''' هو مضاد للقىء يعمل بمثابة مناهض لمستقبلات 5-HT3. [[Category:5-HT3 antagonists]]

...[سيروتونين]] 5-HT3. له تأثيرات مضادة للقىء كما هو الحال مع غيرها من مضادات 5-HT3، وأيضا له آثار مزيلة للقلق وبشكل أقوى بكث [[Category:5-HT3 antagonists]]

* ''[[5-HT3 antagonist|5-HT₃ antagonists]]'' * ''[[dopamine antagonist|primarily dopamine antagonists]]''

[[Category:5-HT3 antagonists]] [[Category:Glycine receptor antagonists]]

[[Category:5-HT3 antagonists]] [[Category:Glycine receptor antagonists]]

'''تروبيسيترون''' هو مناهض لمستقبلات ال[[سيروتونين]] 5-HT3 تستخدم باعتباره مضاد للقىء ولعلاج الغثيا يعمل تروبيسترون على حد سواء كمناهض انتقائي لمستقبلات 5-HT3 وكناهض لمستقبلات α7 النيكوتينية.

[[Category:5-HT3 antagonists]]

'''سيلانسيترون Cilansetron''' هو دواء مناهض للـ 5-HT3 في طور التجارب حالياً في المملكة المتحدة

*[[5-HT3 antagonist|5-HT₃ receptor antagonists]] – these block [[serotonin]] receptors in the [[central nervous system]] * [[Antihistamine]]s ([[Histamine receptor|H₁ histamine receptor]] antagonists), effective in many conditions, including motion sickness, morning sickness

{{5-HT3 antagonists}} [[Category:5-HT3 antagonists]]

{{Neuropeptide agonists and antagonists}} [[Category:NK1 receptor antagonists]]

...apine]], etc){{•}} [[Serotonin antagonist and reuptake inhibitor|Serotonin Antagonists and Reuptake Inhibitor]]s ([[Trazodone]], [[Nefazodone]]){{•}} [[Typical ...fluoromethyl toluidide|HTMT]]{{•}} [[Impromidine]]{{•}} [[UR-AK49]]<br/>'''Antagonists''': [[Cimetidine]]{{•}} [[Famotidine]]{{•}} [[Lafutidine]]{{•}} [[Lav

| group7 = [[Melanin-concentrating hormone receptor 1|MCH₁ antagonists]]

[[Category:NK1 receptor antagonists]]

{{Neuropeptide agonists and antagonists}} [[Category:NK1 receptor antagonists]]

...epressant]]s:''' ''[[Serotonin antagonist and reuptake inhibitor|Serotonin antagonists and reuptake inhibitor]]s'' ([[Trazodone]])&nbsp;• ''[[Tricyclic antidepr | group6 = [[5-HT2A receptor|5-HT_2A]]<br/> antagonists

...mine]] * [[Histamine trifluoromethyl toluidide|HTMT]] * [[UR-AK49]]<br/>'''Antagonists''': ''1st generation'': [[4-Methyldiphenhydramine]] * [[Alimemazine]] * [[A ...ne trifluoromethyl toluidide|HTMT]] * [[Impromidine]] * [[UR-AK49]]<br/>'''Antagonists''': [[Bisfentidine]] [[Burimamide]] * [[Cimetidine]] * [[Dalcotidine]] * [[

{{Neuropeptide agonists and antagonists}} [[Category:NK1 receptor antagonists]]

{{Neuropeptide agonists and antagonists}} [[Category:NK1 receptor antagonists]]

| group2 = [[Cannabinoid receptor antagonist|Cannabinoid<br />receptor antagonists]]

* [[Unifiram]]<br/>'''Antagonists:''' [[ATPO]] ...ermine]]<br/>'''[[NMDA receptor antagonist|Antagonists]]:''' ''Competitive antagonists:'' [[AP5|AP5 (APV)]]

'''Antagonists:''' ''Main site:'' [[Bicuculline]] * [[GS-39783]]<br>'''Antagonists:''' ''Main site:'' [[CGP-35348]]

[[Category:Dopamine antagonists]]

...me="pmid2639158">{{cite journal |author=Hampf G |title=Effect of serotonin antagonists on patients with atypical facial pain |journal=J Craniomandib Disord |volum

* ''Antagonists:'' [[1-850]]

| group1 = Antagonists

* ''Antagonists:'' ''Peptide:'' [[ADP-400]] * ''Antagonists:'' ''Peptide:'' [[ADP-400]]

...[[Dissociative]]s<br />''<small>[[NMDA receptor|NMDAR]] [[NMDA antagonist|antagonists]]</small>'' ...r />''<small>[[Muscarinic acetylcholine receptor|mAChR]] [[Anticholinergic|antagonists]]</small>''

...barbiturates. I. Effects of barbiturates on the convulsive action of GABA-antagonists |journal=Acta Physiologica et Pharmacologica Bulgarica |year=1987 |volume=1

[[Category:Dopamine antagonists]]

...| group1 = <small>[[Serotonin antagonist and reuptake inhibitor|Serotonin antagonists and reuptake inhibitor]]s (SARIs)</small>

[[Category:Nicotinic antagonists]]

[[Category:Dopamine antagonists]]

[[Category:Muscarinic antagonists]]

| group3 = Antagonists | group2 = Antagonists

[[Category:NMDA receptor antagonists]] [[Category:Nicotinic antagonists]]

...= Paton DM, Webster DR | title = Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines) | journal = Clinical Pharmacokinetics | volume = 10 |

| group12 = Narcotic Antagonists

* [[Serotonin antagonists and reuptake inhibitors]]

| group2 = Antagonists | group2 = Antagonists

...ine]] • [[Pseudoephedrine]] • [[Synephrine]] • [[Tetrahydrozoline]]<br/>'''Antagonists''': [[Abanoquil]] • [[Adimolol]] • [[Ajmalicine]] • [[Alfuzosin]] • ...• [[Tolonidine]] • [[Urapidil]] • [[Xylazine]] • [[Xylometazoline]]<br/>'''Antagonists''': [[1-(2-Pyrimidinyl)piperazine|1-PP]] • [[Adimolol]] • [[Atipamezole

...]] • [[VU-0238429]] • [[WAY-132,983]] • [[Xanomeline]] • [[YM-796]]<br/>'''Antagonists''': [[3-Quinuclidinyl benzilate|3-Quinuclidinyl Benzilate]] • [[1,1-Dimet ...ne]] • [[Tropisetron]] • [[UB-165]] • [[Varenicline]] • [[XY-4083]]<br/>'''Antagonists''': [[18-Methoxycoronaridine]] • [[α-bungarotoxin|α-Bungarotoxin]] •

[[Category:D2 antagonists]]